| Date Filed | Type | Description |
| 03/02/2023 |
4
| Funck, Jr. Robert E. (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 11,500 shares
@ $99.77, valued at
$1.1M
Sold 1,264 shares
@ $100.7, valued at
$127.3k
|
|
| 02/22/2023 |
4
| Funck, Jr. Robert E. (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 24,419 shares
@ $0
Granted 96,301 options to buy
@ $106.24, valued at
$10.2M
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2020 |
4
| Funck Robert E (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Gifted 20,000 shares
@ $0
Gifted 10,000 shares
@ $0 |
|
| 10/28/2020 |
4
| Funck Robert E (Executive Vice President & CFO) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 83,333 shares
@ $108.8279, valued at
$9.1M
Exercised 83,333 options to buy
@ $38.4, valued at
$3.2M
|
|
| 04/23/2020 |
4
| Funck Robert E (Executive Vice President & CFO) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 23,855 shares
@ $98, valued at
$2.3M
Exercised 23,700 options to buy
@ $34.94, valued at
$828.1k
Exercised 13,000 options to buy
@ $39.12, valued at
$508.6k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2019 |
4
| Funck Robert E (Senior Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 26,818 shares
@ $85.56, valued at
$2.3M
Exercised 40,000 options to buy
@ $34.94, valued at
$1.4M
|
|
| 03/04/2019 |
4
| Funck Robert E (Senior Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 4,680 shares
@ $77.23, valued at
$361.4k
Sold 1,002 shares
@ $78, valued at
$78.2k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/07/2018 |
4
| Funck Robert E (Senior Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 23,751 shares
@ $67.11, valued at
$1.6M
Exercised 9,700 options to buy
@ $26.1879, valued at
$254k
Exercised 12,300 options to buy
@ $22.3919, valued at
$275.4k
Exercised 14,400 options to buy
@ $27.0336, valued at
$389.3k
|
|
| 06/07/2018 |
4
| Funck Robert E (Senior Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 8,613 shares
@ $63.02, valued at
$542.8k
Exercised 12,800 options to buy
@ $26.015, valued at
$333k
|
|
| 03/02/2018 |
4
| Funck Robert E (Senior Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 2,654 shares
@ $60.55, valued at
$160.7k
Sold 1,220 shares
@ $58.992, valued at
$72k
|
|
| 02/21/2018 |
4
| Funck Robert E (Vice President, Controller) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 20,030 shares
@ $0
Granted 110,146 options to buy
@ $59.94, valued at
$6.6M
|
|
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2016 |
4
| Funck Robert E (Vice President, Controller) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 2,838 shares
@ $39.52, valued at
$112.2k
Sold 933 shares
@ $39.305, valued at
$36.7k
Sold 100 shares
@ $39.304, valued at
$3.9k
Sold 300 shares
@ $39.3023, valued at
$11.8k
|
|
| 02/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/30/2015 |
4
| Funck Robert E (Vice President, Controller) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 17,763 shares
@ $50.94, valued at
$904.8k
Exercised 26,000 options to buy
@ $21.2194, valued at
$551.7k
|
|
| 03/03/2015 |
4
| Funck Robert E (Vice President, Controller) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 2,922 shares
@ $47.61, valued at
$139.1k
|
|
| 02/24/2015 |
4
| Funck Robert E (Vice President, Controller) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 7,819 shares
@ $0
Granted 55,097 options to buy
@ $47, valued at
$2.6M
|
|
| 02/17/2015 |
4
| Funck Robert E (Vice President, Controller) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 6,917 shares
@ $45.22, valued at
$312.8k
Exercised 10,542 options to buy
@ $22.267, valued at
$234.7k
|
|
| 03/04/2014 |
4
| Funck Robert E (Vice President, Controller) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 3,129 shares
@ $39.79, valued at
$124.5k
Sold 713 shares
@ $38.971, valued at
$27.8k
Sold 700 shares
@ $38.974, valued at
$27.3k
|
|
| 02/25/2014 |
4
| Funck Robert E (Vice President, Controller) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 7,240 shares
@ $0
Granted 44,325 options to buy
@ $39.12, valued at
$1.7M
|
|
| 02/04/2014 |
4
| Funck Robert E (Vice President, Controller) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Sold 2,598 shares
@ $36.19, valued at
$94k
Sold 5,608 shares
@ $36.2, valued at
$203k
Sold 1,192 shares
@ $36.21, valued at
$43.2k
Exercised 2,137 options to buy
@ $31.6081, valued at
$67.5k
Exercised 5,715 options to buy
@ $33.88, valued at
$193.6k
Exercised 1,546 options to buy
@ $35.08, valued at
$54.2k
|
|
| 03/08/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |